Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health
Chelsea N. Fries, Elizabeth J. Curvino, Jui‐Lin Chen, et al.
Nature Nanotechnology (2020) Vol. 16, Iss. 4, pp. 1-14
Open Access | Times Cited: 194

Showing 1-25 of 194 citing articles:

COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung, Melissa N. Thone, Young Jik Kwon
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 1-25
Open Access | Times Cited: 352
Novel approaches for vaccine development
Makda S. Gebre, Luis A. Brito, Lisa H. Tostanoski, et al.
Cell (2021) Vol. 184, Iss. 6, pp. 1589-1603
Open Access | Times Cited: 238
Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
William Ho, Mingzhu Gao, Fengqiao Li, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 8
Open Access | Times Cited: 205
Gold nanoparticles (GNPs) in biomedical and clinical applications: A review
Muzahidul I. Anik, Niaz Mahmud, Abdullah Al Masud, et al.
Nano Select (2021) Vol. 3, Iss. 4, pp. 792-828
Closed Access | Times Cited: 132
Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 131
Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies
Nayanika Chakraborty, Diksha Jha, Indrajit Roy, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 95
Semiconducting Polymer Nanoparticles with Surface‐Mimicking Protein Secondary Structure as Lysosome‐Targeting Chimaeras for Self‐Synergistic Cancer Immunotherapy
Ji Qi, Shaorui Jia, Xiaoying Kang, et al.
Advanced Materials (2022) Vol. 34, Iss. 31
Closed Access | Times Cited: 92
Emerging vaccine nanotechnology: From defense against infection to sniping cancer
Chan Feng, Yongjiang Li, Bijan Emiliano Ferdows, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 5, pp. 2206-2223
Open Access | Times Cited: 89
Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 72
A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion
Seung Mo Jin, Yeon Jeong Yoo, Hong Sik Shin, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 4, pp. 390-402
Open Access | Times Cited: 70
Accelerating the prediction and discovery of peptide hydrogels with human-in-the-loop
Tengyan Xu, Jiaqi Wang, Shuang Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 60
Immune imprinting and next-generation coronavirus vaccines
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1971-1985
Closed Access | Times Cited: 43
Green synthesis of antibacterial and cytotoxic silver nanoparticles by Piper nigrum seed extract and development of antibacterial silver based chitosan nanocomposite
Kanniah Paulkumar, C. Parvathiraja, Jesi Reeta Thangapandi, et al.
International Journal of Biological Macromolecules (2021) Vol. 189, pp. 18-33
Closed Access | Times Cited: 94
Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
Fahad Albalawi, Mohd Zobir Hussein, Sharida Fakurazi, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 161-184
Open Access | Times Cited: 84
Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus
Yaling Wang, Yuping Xie, Jia Luo, et al.
Nano Today (2021) Vol. 38, pp. 101139-101139
Open Access | Times Cited: 82
Nanovaccine: an emerging strategy
Amrita Das, Nahid Ali
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1273-1290
Closed Access | Times Cited: 80
Targeted Enrichment of Enzyme‐Instructed Assemblies in Cancer Cell Lysosomes Turns Immunologically Cold Tumors Hot
Shenglu Ji, Jun Li, Xingchen Duan, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 52, pp. 26994-27004
Closed Access | Times Cited: 73
Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle
Uday Kumar Sukumar, Rayhaneh Afjei, Katherine W. Ferrara, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17582-17601
Open Access | Times Cited: 72
Bacteria eat nanoprobes for aggregation-enhanced imaging and killing diverse microorganisms
Yunmin Yang, Binbin Chu, Jiayi Cheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 66
Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines
Zhe Sun, Xiaodong Sun, Zhanwei Chen, et al.
International Journal of Peptide Research and Therapeutics (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 62
Highly reversible aqueous zinc metal batteries enabled by fluorinated interphases in localized high concentration electrolytes
Shunqiang Chen, Qingshun Nian, Lei Zheng, et al.
Journal of Materials Chemistry A (2021) Vol. 9, Iss. 39, pp. 22347-22352
Closed Access | Times Cited: 58
Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery
Audrey Olshefsky, Christian Richardson, Suzie H. Pun, et al.
Bioconjugate Chemistry (2022) Vol. 33, Iss. 11, pp. 2018-2034
Open Access | Times Cited: 53
Biological Nanoparticles in Vaccine Development
Stephanie M. Curley, David Putnam
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 42
Engineering nanomaterial physical characteristics for cancer immunotherapy
DaeYong Lee, Kristin Huntoon, Jacques Lux, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 7, pp. 499-517
Closed Access | Times Cited: 36
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top